T. Rowe Price Associates’s Elevance Health ELV Stock Holding History

T. Rowe Price Associates’s Portfolio ELV Stock Details ELV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.14B	Sell	8,085,205 -1,057,358	-12%	-$411M	0.36%	48
2025 Q1	$3.98B	Sell	9,142,563 -1,475,499	-14%	-$642M	0.49%	35
2024 Q4	$3.92B	Buy	10,618,062 +464,137	+5%	+$171M	0.45%	37
2024 Q3	$5.28B	Sell	10,153,925 -1,492,601	-13%	-$776M	0.61%	25
2024 Q2	$6.31B	Sell	11,646,526 -73,734	-0.6%	-$40M	0.76%	14
2024 Q1	$6.08B	Sell	11,720,260 -203,333	-2%	-$105M	0.74%	17
2023 Q4	$5.62B	Sell	11,923,593 -107,780	-0.9%	-$50.8M	0.76%	18
2023 Q3	$5.24B	Sell	12,031,373 -70,184	-0.6%	-$30.6M	0.77%	17
2023 Q2	$5.38B	Sell	12,101,557 -1,175,613	-9%	-$522M	0.75%	19
2023 Q1	$6.1B	Buy	13,277,170 +551,614	+4%	+$254M	0.91%	14
2022 Q4	$6.53B	Buy	12,725,556 +1,979,665	+18%	+$1.02B	1.05%	11
2022 Q3	$4.88B	Buy	10,745,891 +1,290,134	+14%	+$586M	0.8%	16
2022 Q2	$4.56B	Buy	9,455,757 +699,906	+8%	+$338M	0.58%	27
2022 Q1	$4.3B	Sell	8,755,851 -1,047,018	-11%	-$514M	0.43%	37
2021 Q4	$4.54B	Sell	9,802,869 -20,557	-0.2%	-$9.53M	0.41%	40
2021 Q3	$3.66B	Sell	9,823,426 -2,376,773	-19%	-$886M	0.34%	53
2021 Q2	$4.66B	Sell	12,200,199 -486,365	-4%	-$186M	0.43%	38
2021 Q1	$4.55B	Buy	12,686,564 +715,968	+6%	+$257M	0.46%	34
2020 Q4	$3.84B	Sell	11,970,596 -1,730,192	-13%	-$555M	0.39%	52
2020 Q3	$3.68B	Sell	13,700,788 -507,264	-4%	-$136M	0.43%	42
2020 Q2	$3.74B	Buy	14,208,052 +625,569	+5%	+$165M	0.47%	41
2020 Q1	$3.08B	Buy	13,582,483 +2,066,343	+18%	+$469M	0.49%	35
2019 Q4	$3.48B	Sell	11,516,140 -362,880	-3%	-$110M	0.45%	42
2019 Q3	$2.85B	Sell	11,879,020 -5,077,178	-30%	-$1.22B	0.4%	51
2019 Q2	$4.79B	Sell	16,956,198 -2,328,453	-12%	-$657M	0.67%	23
2019 Q1	$5.53B	Sell	19,284,651 -451,762	-2%	-$130M	0.81%	15
2018 Q4	$5.18B	Buy	19,736,413 +1,197,941	+6%	+$315M	0.88%	14
2018 Q3	$5.08B	Sell	18,538,472 -35,669	-0.2%	-$9.78M	0.74%	17
2018 Q2	$4.42B	Buy	18,574,141 +418,984	+2%	+$99.7M	0.68%	22
2018 Q1	$3.99B	Buy	18,155,157 +1,285,990	+8%	+$283M	0.63%	27
2017 Q4	$3.8B	Buy	16,869,167 +2,419,549	+17%	+$544M	0.62%	26
2017 Q3	$2.74B	Buy	14,449,618 +903,197	+7%	+$171M	0.47%	43
2017 Q2	$2.55B	Buy	13,546,421 +460,630	+4%	+$86.7M	0.46%	43
2017 Q1	$2.16B	Sell	13,085,791 -691,953	-5%	-$114M	0.41%	51
2016 Q4	$1.98B	Sell	13,777,744 -1,181,496	-8%	-$170M	0.39%	56
2016 Q3	$1.87B	Sell	14,959,240 -5,785,576	-28%	-$725M	0.38%	61
2016 Q2	$2.72B	Sell	20,744,816 -3,862,731	-16%	-$507M	0.58%	31
2016 Q1	$3.42B	Sell	24,607,547 -1,233,148	-5%	-$171M	0.73%	22
2015 Q4	$3.6B	Buy	25,840,695 +2,421,033	+10%	+$338M	0.76%	21
2015 Q3	$3.28B	Buy	23,419,662 +7,748,867	+49%	+$1.08B	0.73%	22
2015 Q2	$2.57B	Buy	15,670,795 +4,104,738	+35%	+$674M	0.53%	37
2015 Q1	$1.79B	Buy	11,566,057 +6,343,303	+121%	+$979M	0.37%	59
2014 Q4	$656M	Buy	5,222,754 +306,508	+6%	+$38.5M	0.14%	187
2014 Q3	$588M	Buy	4,916,246 +802,496	+20%	+$96M	0.13%	190
2014 Q2	$443M	Buy	4,113,750 +125,822	+3%	+$13.5M	0.1%	248
2014 Q1	$397M	Sell	3,987,928 -1,249,527	-24%	-$124M	0.09%	265
2013 Q4	$484M	Sell	5,237,455 -443,311	-8%	-$41M	0.11%	219
2013 Q3	$475M	Buy	5,680,766 +2,248,840	+66%	+$188M	0.12%	219
2013 Q2	$281M	Buy	+3,431,926	New	+$281M	0.08%	312